John F. Tisdale

16.1k total citations · 3 hit papers
267 papers, 10.0k citations indexed

About

John F. Tisdale is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, John F. Tisdale has authored 267 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Genetics, 109 papers in Molecular Biology and 101 papers in Hematology. Recurrent topics in John F. Tisdale's work include Hemoglobinopathies and Related Disorders (119 papers), Virus-based gene therapy research (83 papers) and Hematopoietic Stem Cell Transplantation (56 papers). John F. Tisdale is often cited by papers focused on Hemoglobinopathies and Related Disorders (119 papers), Virus-based gene therapy research (83 papers) and Hematopoietic Stem Cell Transplantation (56 papers). John F. Tisdale collaborates with scholars based in United States, Germany and France. John F. Tisdale's co-authors include Matthew M. Hsieh, Cynthia E. Dunbar, Courtney D. Fitzhugh, Naoya Uchida, Shira Perl, Robert E. Donahue, Kanar Alkass, Göran Possnert, Griffin P. Rodgers and Jonas Frisén and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

John F. Tisdale

258 papers receiving 9.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

2000 770 citations Richard Childs, Susan F. Leitman et al. profile →
Neurogenesis in the Striatum of the Adult Human Brain

2014 705 citations John F. Tisdale et al. profile →
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice

2023 85 citations Kelcee A. Everette, Gregory A. Newby et al. Nature Biomedical Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John F. Tisdale United States	49	3.6k	3.4k	3.1k	2.4k	1.6k	267	10.0k
Hirofumi Hamada Japan	53	5.7k 1.6×	1.5k 0.4×	2.8k 0.9×	2.0k 0.8×	2.0k 1.2×	227	11.7k
Magda Kucia United States	65	8.1k 2.2×	1.8k 0.5×	4.4k 1.4×	663 0.3×	2.9k 1.8×	259	14.6k
Keiya Ozawa Japan	60	6.3k 1.8×	1.9k 0.6×	2.5k 0.8×	2.8k 1.2×	1.6k 1.0×	339	12.1k
Derrick J. Rossi United States	52	10.3k 2.9×	3.4k 1.0×	1.8k 0.6×	1.5k 0.6×	3.4k 2.1×	90	15.7k
Karl V. Voelkerding United States	32	11.2k 3.1×	1.2k 0.3×	1.6k 0.5×	9.8k 4.1×	1.4k 0.8×	86	23.1k
Jeanne Amiel France	60	6.5k 1.8×	712 0.2×	1.1k 0.4×	3.2k 1.4×	990 0.6×	324	14.2k
Ad Geurts van Kessel Netherlands	63	8.0k 2.2×	2.5k 0.7×	2.1k 0.7×	4.8k 2.0×	1.2k 0.8×	256	15.6k
Lucy A. Godley United States	49	5.7k 1.6×	4.0k 1.2×	1.6k 0.5×	1.4k 0.6×	926 0.6×	228	9.7k
Elaine Lyon United States	30	10.9k 3.0×	1.1k 0.3×	1.7k 0.5×	10.3k 4.3×	1.1k 0.6×	102	23.2k
Mark W. Kieran United States	65	6.7k 1.9×	730 0.2×	3.9k 1.2×	650 0.3×	2.5k 1.5×	268	14.9k

Countries citing papers authored by John F. Tisdale

Since Specialization

Citations

This map shows the geographic impact of John F. Tisdale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Tisdale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Tisdale more than expected).

Fields of papers citing papers by John F. Tisdale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Tisdale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Tisdale. The network helps show where John F. Tisdale may publish in the future.

Co-authorship network of co-authors of John F. Tisdale

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Tisdale. A scholar is included among the top collaborators of John F. Tisdale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Tisdale. John F. Tisdale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeffries, Neal, Mary Link, Wynona Coles, et al.. (2025). Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease. Transplantation and Cellular Therapy. 31(5). 305–318. 1 indexed citations

Marco, Eugenio, Patricia Sousa, Jack Heath, et al.. (2025). Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT. Molecular Therapy. 34(1). 249–265.

Kanter, Julie, Melissa A. Kinney, Janet L. Kwiatkowski, et al.. (2024). An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel. Blood. 144(Supplement 1). 511–511. 3 indexed citations

Hsieh, Matthew M., et al.. (2023). Abstract 35: Changes In Sickle Cell Vasculopathy After Hematopoietic Stem Cell Transplantation. Stroke. 54(Suppl_1). 1 indexed citations

Everette, Kelcee A., Gregory A. Newby, Rachel M. Levine, et al.. (2023). Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nature Biomedical Engineering. 7(5). 616–628. 85 indexed citations breakdown →

Sharma, Akshay, Alexis Leonard, Kamille A. West, et al.. (2022). Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor‐mobilized patients with sickle cell disease. British Journal of Haematology. 198(4). 740–744. 13 indexed citations

Uchida, Naoya, Francesca Ferrara, Claire Drysdale, et al.. (2021). Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and coexpressed truncated erythropoietin receptor. Science Translational Medicine. 13(591). 7 indexed citations

Walters, Mark C., Alexis A. Thompson, Markus Y. Mapara, et al.. (2021). Resolution of Serious Vaso-Occlusive Pain Crises: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy. Transplantation and Cellular Therapy. 27(3). S12–S13. 1 indexed citations

Thompson, Alexis A., Mark C. Walters, Markus Y. Mapara, et al.. (2020). Resolution of Serious Vaso-Occlusive Pain Crises and Reduction in Patient-Reported Pain Intensity: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy. Blood. 136(Supplement 1). 16–17. 9 indexed citations

10.

Yakov, Gil Ben, Hawwa Alao, Pallavi Surana, et al.. (2019). Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?. British Journal of Haematology. 187(1). 117–123. 7 indexed citations

11.

Allen, Elizabeth S., Kshitij Srivastava, Matthew M. Hsieh, et al.. (2017). Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study. The Lancet Haematology. 4(11). e553–e561. 21 indexed citations

12.

Espinoza, Diego A., Chuanfeng Wu, Xing Fan, et al.. (2017). Aberrant Clonal Hematopoiesis of the Erythroid and Myeloid Lineages in a Lentivirally Barcoded Rhesus Macaque. Blood. 130. 606–606. 1 indexed citations

13.

Demirci, Selami, Saurabh K. Bhardwaj, Naoya Uchida, et al.. (2017). Fetal Hemoglobin Induction with Forced Chromatin Looping in Gene-Modified Erythroid Cells Differentiated from Rhesus Hematopoietic Progenitor Cells. Blood. 130. 4617–4617. 1 indexed citations

14.

Uchida, Naoya, Atsushi Fujita, Matthew M. Hsieh, et al.. (2017). Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients. PubMed. 28(3). 136–144. 22 indexed citations

15.

Renoux, Céline, Nermi L. Parrow, Camille Faës, et al.. (2015). Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia. Clinical Hemorheology and Microcirculation. 62(2). 173–179. 28 indexed citations

16.

Ye, Hong, Suh Young Jeong, Manik C. Ghosh, et al.. (2010). Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. Journal of Clinical Investigation. 120(5). 1749–1761. 187 indexed citations

17.

Stroncek, David F., Hanh Khuu, John F. Tisdale, et al.. (2005). Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor. Experimental Hematology. 33(10). 1109–1117. 12 indexed citations

18.

Gao, Chunji, Elizabeth M. Kang, Ken Kuramoto, et al.. (2003). Retrovirally transduced muscle-derived cells contribute to hematopoiesis at very low levels in the nonhuman primate model. Molecular Therapy. 8(6). 974–980. 4 indexed citations

19.

Tisdale, John F. & Cynthia E. Dunbar. (2002). Plasticity and hematopoiesis: Circe's transforming potion?. Current Opinion in Hematology. 9(4). 268–273. 6 indexed citations

20.

Kang, Elizabeth M., Moniek de Witte, Harry L. Malech, et al.. (2002). Gene Therapy–based Treatment for HIV-Positive Patients with Malignancies. Journal of Hematotherapy & Stem Cell Research. 11(5). 809–816. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact